Previous close | 23.49 |
Open | 21.28 |
Bid | 20.85 |
Ask | 21.25 |
Strike | 140.00 |
Expiry date | 2025-01-17 |
Day's range | 21.10 - 21.30 |
Contract range | N/A |
Volume | |
Open interest | 370 |
There's no better time than October to invest in high-quality dividend stocks. Three Motley Fool contributors believe they've identified magnificent dividend stocks to buy in October. Here's why they chose AbbVie (NYSE: ABBV), Gilead Sciences (NASDAQ: GILD), and Johnson & Johnson (NYSE: JNJ).
The European Commission approves AbbVie's (ABBV) Tepkinly (epcoritamab) for DLBCL. FDA approves Lilly's (LLY) Jardiance for chronic kidney disease.
Zacks.com users have recently been watching AbbVie (ABBV) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.